The French Valneva prepares for its IPO in the United States
The French biotech specialized in vaccines Valneva announced on Saturday the filing of a registration document (Form F-1) with the American Securities and Exchange Commission for its initial public offering in the United States. The company said in a statement that in the … – – – – .